Structural Equation Modeling of Adherence to Treatment Based on Cognitive Function Mediating Role of Coping Strategies in Women with Breast Cancer Undergoing Chemotherapy
International Journal of Applied Behavioral Sciences,
Vol. 9 No. 1 (2022),
31 May 2022
,
Page 10-19
https://doi.org/10.22037/ijabs.v9i1.32841
Abstract
Background and Aim:The present study aimed to investigate the structural equations of treatment adherence based on cognitive function mediated by coping styles in women with breast cancer undergoing chemotherapy.
Materials and Methods:The present study was correlational and structural equation modeling. The statistical population included patients with breast cancer referred to specialized cancer clinics in Tehran between October and February 2017. The sample consisted of 250 patients with breast cancer who were selected by voluntary sampling. Data were obtained using the Folkman and Lazarus Coping Strategies Questionnaire, the Cognitive Function Questionnaire, and Morisky Medication Adherence Scale (MMAS-8). Data were also analyzed using correlation coefficient, Pearson correlation matrix, multiple regression, and structural equation modeling. Also, all statistical calculations were performed using Amos.22 and SPSS.22 software.
Results:The results showed that cognitive function had a direct effect on coping strategies (β=0.48, P<0.001) and adherence to treatment (β=0.63, P<0.001). Coping strategies had a mediating role in the relationship between cognitive function and adherence to treatment.
Conclusion:It can be concluded that cancer and the patient's necessity to follow treatment cause many challenges in daily life that necessitate the use of coping styles to adapt, coping styles play an important role in the course, control and psychosocial adjustment of the patient with cancer can have
- Cognitive function, Coping strategies, Adherence, Breast cancer
How to Cite
References
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, Van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Jama. 2017;317(23):2402-16.
Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B. Associations between cancer predisposition testing panel genes and breast cancer. JAMA oncology. 2017;3(9):1190-6.
Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer Jr CE, Dees EC, Goetz MP, Olson Jr JA, Lively T. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111-21.
Goetz MP, Toi M, Campone M, Trédan O, Bourayou N, Sohn J, et al. MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer. J Clin Oncol. 2017; 3(2):55-60.
Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377(6):523-33.
O’Byrne ML, Shinohara RT, Grant EK, Kanter JP, Gillespie MJ, Dori Y, et al. Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database. Am Heart J. 2017;192:85–97.
Xie X, Bratec SM, Schmid G, Meng C, Doll A, Wohlschläger A, Finke K, Förstl H, Zimmer C, Pekrun R, Schilbach L. How do you make me feel better? Social cognitive cognitive function and the default mode network. NeuroImage. 2016;134:270-80.
Potthoff S, Garnefski N, Miklósi M, Ubbiali A, Domínguez-Sánchez FJ, Martins EC, et al. Cognitive emotion regulation and psychopathology across cultures: A comparison between six European countries. Pers Individ Dif. 2016;98:218–24.
Tierney S, Burns J, Kilbey E. Looking behind the mask: Social coping strategies of girls on the autistic spectrum. Res Autism Spectr Disord. 2016;23:73–83.
Fox J, Tang WY. Women’s experiences with general and sexual harassment in online video games: Rumination, organizational responsiveness, withdrawal, and coping strategies. New Media Soc. 2017;19(8):1290–307.
Holton MK, Barry AE, Chaney JD. Employee stress management: An examination of adaptive and maladaptive coping strategies on employee health. Work. 2016;53(2):299-305.
Nipp RD, El‐Jawahri A, Fishbein JN, Eusebio J, Stagl JM, Gallagher ER, Park ER, Jackson VA, Pirl WF, Greer JA, Temel JS. The relationship between coping strategies, quality of life, and mood in patients with incurable cancer. Cancer. 2016;122(13):2110-6.
Fares J, Saadeddin Z, Al Tabosh H, Aridi H, El Mouhayyar C, Koleilat MK, et al. Extracurricular activities associated with stress and burnout in preclinical medical students. J Epidemiol Glob Health. 2016;6(3):177–85.
Palmer CA, Alfano CA. Sleep and cognitive function: an organizing, integrative review. Sleep Med Rev. 2017;31:6-16.
Brockman R, Ciarrochi J, Parker P, Kashdan T. Cognitive function strategies in daily life: Mindfulness, cognitive reappraisal and emotion suppression. Cogn Behav Ther. 2017;46(2):91-113.
Naragon-Gainey K, McMahon TP, Chacko TP. The structure of common cognitive function strategies: A meta-analytic examination. Psychol Bull. 2017;143(4):384.
Meggiolaro E, Berardi MA, Andritsch E, Nanni MG, Sirgo A, Samorì E, et al. Cancer patients’ emotional distress, coping styles and perception of doctor-patient interaction in European cancer settings. Palliat Support Care. 2016;14(3):204–11.
Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.
Banegas MP, Emerson MA, Adams AS, Achacoso NS, Chawla N, Alexeeff S, et al. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer. J Cancer Surviv. 2018;12(6):794–802.
Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163(2):506-19.
Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147-59.
Folkman S, Lazarus RS. Coping as a Mediator of Emotion. J Pers Soc Psychol. 1988;54(3):466–75.
Abravani P, Gharibzadeh S. Coping strategies during COVID-19 outbreak in Islamic Republic of Iran. J Exp Clin Neuro. 2020;7(2):54-62.
Morris R, Smulders K, Peterson DS, Mancini M, Carlson-Kuhta P, Nutt JG, et al. Cognitive function in people with and without freezing of gait in Parkinson’s disease. npj Park Dis. 2020;6(1):37-46.
Martinez-Perez P, Orozco-Beltrán D, Pomares-Gomez F, Hernández-Rizo JL, Borras-Gallen A, Gil-Guillen VF, et al. Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in type 2 diabetes patients in Spain. Aten Primaria. 2021;53(2).
Ranjbaran S, Shojaeizadeh D, Dehdari T, Yaseri M, Shakibazadeh E. Determinants of medication adherence among Iranian patients with type 2 diabetes: An application of health action process approach. Heliyon. 2020;6(7):22-36.
Massey EK, Meys K, Kerner R, Weimar W, Roodnat J, Cransberg K. Young adult kidney transplant recipients: Nonadherent and happy. Transplantation. 2015;99(8): 89–96.
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W. Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med. 2016;375(18):1738-48.
Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, et al. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):290–303.
Hamama‐Raz Y, Pat‐Horenczyk R, Roziner I, Perry S, Stemmer SM. Can posttraumatic growth after breast cancer promote positive coping? A cross‐lagged study. Psycho‐oncology. 2019;28(4):767-74.
Lake B, Fuller HR, Rastall S, Usman T. Breast Reconstruction Affects Coping Mechanisms in Breast Cancer Survivors. Indian J Surg. 2019;81(1):43–50.
Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018;9(1):1-6.
Varshosaz P, Kalantari F. A Double-Blind Randomized Controlled Trial on the Effectiveness of Acceptance and Commitment Therapy on Resiliency, Anxiety and Perceived Stress in Women with Breast Cancer. IJABS. 2018; 5(4):29-35.
Kabiri M, Bazzazian S, Amirimajd M, Ghamari M. Effectiveness of Object Relation Approach on Ego Strength and Communicational Patterns among Married Women with Breast Cancer. IJABS. 2019;5(3):18-26.
Sadeghi F, Hassani F, Emamipour S, Mirzaie H. Comparison of cognitive behavioral group therapy and acceptance and commitment group therapy on quality of life of breast cancer women. IJABS. 2017;4(2):17-23.
- Abstract Viewed: 243 times
- PdF Downloaded: 213 times